Skip to main content

Worldwide Spending on Cancer Drugs Hits $100 Billion

Global spending on cancer drugs hit $100 billion last year, prompted by new and patented drugs, broader insurance coverage and aging populations. That figure is up more than 10 percent since 2013.

Republish
Lead image for this article
Credit: Linus Ekenstam

Global spending on cancer drugs hit $100 billion last year, prompted by new and patented drugs, broader insurance coverage and aging populations. That figure is up slightly more than 10 percent since 2013. (Modern Healthcare)

Texans need truth. Help us report it.

Independent Texas reporting needs your support. The Texas Tribune delivers fact-based journalism for Texans, by Texans — and our community of members, the readers who donate, make our work possible. Help us bring you and millions of others in-depth news and information. Will you support our nonprofit newsroom with a donation of any amount?

Support independent Texas news

Become a member. Join today.

Choose an amount or learn more about membership.

$20 $25 $50 Other
Donate now

Information about the authors

Christine Ayala’s staff photo

Learn about The Texas Tribune’s policies, including our partnership with The Trust Project to increase transparency in news.

Explore related story topics